SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
clinical epidemiology
infection control
respiratory infection
viral infection
Journal
Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
27
05
2020
revised:
03
08
2020
accepted:
11
08
2020
pubmed:
13
9
2020
medline:
15
12
2020
entrez:
12
9
2020
Statut:
ppublish
Résumé
To determine the rates of asymptomatic viral carriage and seroprevalence of SARS-CoV-2 antibodies in healthcare workers. A cross-sectional study of asymptomatic healthcare workers undertaken on 24/25 April 2020. University Hospitals Birmingham NHS Foundation Trust (UHBFT), UK. 545 asymptomatic healthcare workers were recruited while at work. Participants were invited to participate via the UHBFT social media. Exclusion criteria included current symptoms consistent with COVID-19. No potential participants were excluded. Participants volunteered a nasopharyngeal swab and a venous blood sample that were tested for SARS-CoV-2 RNA and anti-SARS-CoV-2 spike glycoprotein antibodies, respectively. Results were interpreted in the context of prior illnesses and the hospital departments in which participants worked. Proportion of participants demonstrating infection and positive SARS-CoV-2 serology. The point prevalence of SARS-CoV-2 viral carriage was 2.4% (n=13/545). The overall seroprevalence of SARS-CoV-2 antibodies was 24.4% (n=126/516). Participants who reported prior symptomatic illness had higher seroprevalence (37.5% vs 17.1%, χ We identify differences in the occupational risk of exposure to SARS-CoV-2 between hospital departments and confirm asymptomatic seroconversion occurs in healthcare workers. Further investigation of these observations is required to inform future infection control and occupational health practices.
Identifiants
pubmed: 32917840
pii: thoraxjnl-2020-215414
doi: 10.1136/thoraxjnl-2020-215414
pmc: PMC7462045
doi:
Substances chimiques
Antibodies, Viral
0
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1089-1094Subventions
Organisme : Medical Research Council
ID : MC_PC_17183
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009157/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: MTD reports personal fees from Abingdon Health, outside the submitted work. All other authors declare no competing interests.
Références
Lancet. 2020 May 2;395(10234):1418-1420
pubmed: 32305073
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
JAMA. 2020 Jun 16;323(23):2424-2425
pubmed: 32407440
Elife. 2020 Aug 21;9:
pubmed: 32820721
Emerg Infect Dis. 2005 Jan;11(1):89-94
pubmed: 15705328
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
Clin Infect Dis. 2004 Jun 15;38(12):e116-8
pubmed: 15227633
J Clin Virol. 2020 Jul;128:104469
pubmed: 32474371